US Patent Issued to KYOWA KIRIN, KYOTO UNIVERSITY on May 12 for "Anti-human CCR1 monoclonal antibody" (Japanese Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,113, issued on May 12, was assigned to KYOWA KIRIN Co. LTD. (Tokyo) and KYOTO UNIVERSITY (Kyoto, Japan).

"Anti-human CCR1 monoclonal antibody" was invented by Masayuki Kai (Tokyo), Shinya Ogawa (Tokyo), Makoto Taketo (Kyoto, Japan), Kenji Kawada (Kyoto, Japan), Hideyo Hirai (Kyoto, Japan), Yoshiharu Sakai (Kyoto, Japan) and Taira Maekawa (Kyoto, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "A monoclonal antibody is provided which binds to a human CC chemokine receptor 1 (CCR1) and inhibits activation of the human CCR1, or an antibody fragment thereof. The monoclonal antibody binds to an extracellular region of a human CCR1 and inhibits activat...